Excelsior Sciences was delighted to speak to Savannah Wiegel and Corinna Singleman, PhD at Genetic Engineering & Biotechnology News (GEN). In this comprehensive feature, Savannah explores how the company is working to close the gap between AI-driven molecular design and real-world chemistry through its innovative smart bloccs platform.
The article provides valuable insight into Excelsior Sciences’ founding story: how the COVID-19 pandemic exposed chemistry’s reliance on manual and location-bound workflows and sparked the mission to create an automated and AI-friendly approach. Savannah takes readers inside the Midtown Manhattan facility, where synthesis, purification, and biological testing are tightly integrated within a compact and highly automated space designed to embody the company’s “molecular industrial revolution” vision.
The piece explains how Excelsior Sciences’ modular chemistry system enables programmable carbon-carbon bond formation, creating a chemical language that enables our closed-loop system linking synthesis, biological testing, and AI optimization. As co-founder and CEO Michael Foley emphasizes, the platform is designed not just for discovery but for scalability, reducing the handoffs and complexity that typically slow drug development while enabling more sustainable manufacturing.
